Visceral leishmaniasis, caused by the protozoan parasite Leishmania donovani, is characterized by the loss of ability of the host to generate an effective immune response. In the present study, the comparative potential of CXC chemokines, interferon-g-inducible protein-10 (IP-10) and interleukin-8 (IL-8) in restricting Leishmania donovani infection via the release of nitric oxide and proinflammatory cytokines was studied in an in vitro model. Nitric oxide, a crucial mediator for IP-10-mediated leishmanicidal activity, was found to be dependent on inducible nitric oxide synthase 2 (iNOS2) expression and was linked to the mitogen-activated protein kinases (MAPK) signaling pathway. Further, IP-10 was also able to abrogate the survival of Leishmania in an in vivo model of visceral leishmaniasis by restoration of Th1 cytokines and nitric oxide. Thus, this study strongly demonstrates that IP-10, like CC chemokines, is involved in rendering a protective response in visceral leishmaniasis via up-regulation of proinflammatory mediators.
Visceral leishmaniasis, caused by the protozoan parasite Leishmania donovani, is associated with immunological dysfunctions of T cells, natural killer cells, and macrophages [1] [2] [3] . Leishmania evades the immune system surveillance through depletion of nitric oxide (NO) and reactive oxygen species, which are important microbicidal molecules [4, 5] . Proinflammatory cytokines, such as tumor necrosis factor (TNF)-a and interleukin (IL)-12, are abrogated, whereas anti-inflammatory cytokines, such as IL-10 and transforming growth factor (TGF)-b, are induced following Leishmania infection [6, 7] . Most of the effector functions in response to extracellular cues are regulated by mitogen-activated protein kinases (MAPK) [8, 9] , and the parasite-triggered reciprocal MAPK signaling via extracellular signal-regulated kinase (ERK)1/2 and p38MAPK govern the counteracting immune response of the host cell [10] . Cutaneous leishmaniasis in humans and in mice leads to rapid changes in chemokine expression [11, 12] , suggesting possible involvement of chemokines in the disease process.
Chemokines (8) (9) (10) are an integral part of the host defense against pathogens and have been subdivided into 2 major subfamilies, CC and CXC [13, 14] . Interferon-g-inducible protein 10 (IP-10) and IL-8 are important members of this CXC group. Functionally, chemokines play a key role in the recruitment of immune cells by chemotaxis, leukocyte activation, and hematopoiesis [14, 15] . Exogenous administration of chemokines has shown promising results in the treatment of visceral leishmaniasis [16] . Treatment with CC chemokine leads to a strong Th1 immune response in experimental visceral leishmaniasis [17] . IL-8 is an inducer of angiogenesis and has clinical relevance in psoriasis and rheumatoid arthritis [18] [19] [20] . IP-10, with known antitumor, antiviral, and antifungal activities [21] [22] [23] , induces natural killer cell cytotoxicity, and an early and strong induction of IP-10 was observed in Leishmaniainfected healing B6 mice [24] . Therefore, IP-10 is a potential candidate for immunotherapy to cure visceral leishmaniasis because it promotes recruitment and activation of Th1-polarized cells [25, 26] . The role of these CXC chemokines in the containment of L. donovani infection needs further elucidation.
The present study demonstrates the potential of CXC chemokine in restricting intracellular parasitic growth. IP-10, unlike IL-8, restored the impaired proinflammatory cytokines along with generation of NO. This induction of NO was mediated by inducible NO synthase 2 (iNOS2) and was further linked to the MAPK signaling pathway. In vivo studies showed that IP-10 treatment could mediate effective parasitic killing and bring about the critical shift from Th2 to Th1 immune response along with generation of NO from restimulated splenocytes. These studies might provide crucial cues in understanding the immunomodulatory role of CXC chemokine in rendering protection against visceral leishmaniasis.
MATERIALS AND METHODS
Animals and parasites. BALB/c mice were purchased from the National Center for Laboratory Animal Sciences (India). For each experiment, 8-10 mice (age, 4-6 weeks) were used, regardless of sex. L. donovani strain AG-83 (MHOM/IN/1983/ AG-83) was maintained in vitro in Medium 199 (Sigma) containing 10% fetal calf serum (Gibco BRL). Amastigotes were prepared as described elsewhere [27] . Promastigotes were obtained by suitable transformation. Experiments were performed with promastigotes in the stationary phase. All experimental protocols received prior approval from the Institutional Animal Ethical Committee.
Peritoneal macrophage preparation. Macrophages were isolated by peritoneal lavage with ice-cold phosphate-buffered saline at 48 h after intraperitoneal injection of 1.0 mL of sterile 4% thioglycolate broth (Difco). Cells were cultured as described elsewhere [28] . The adherent cell population was cultured for 48 h prior to any treatment, to achieve the resting state.
Uptake and intracellular multiplication. For assessing the activity of recombinant CXC chemokines against the amastigote stage of parasite, peritoneal macrophages cultured on glass coverslips were pretreated with recombinant IP-10 or IL-8 (endotoxin level !1.0 EU/mg of cytokine; R&D Systems) at a 50 ng/mL concentration for 4 h, followed by infection with L. donovani promastigotes at a ratio of 1:10 for the indicated time periods; macrophages were then fixed and stained as described elsewhere [16] for calculation of the number of intracellular parasites. When indicated, the uptake and multiplication of L. donovani was studied in the presence and absence of the NO synthase inhibitor L-N-monomethyl arginine (L-NMMA; 0.4 mmol/L) [29] , p38MAPK inhibitor SB203580 (10 mg/mL), or ERK inhibitor PD098059 (100 mmol/L; Sigma) [10] .
Cytokine enzyme-linked immunosorbent assay (ELISA). The conditioned medium of macrophage culture was assayed for mouse cytokines and chemokines with use of the sandwich ELISA kit (Quantikine M; R&D Systems). The assay was performed according to the manufacturer's instructions.
Preparation of cell lysate and immunoblot analysis. Cell lysates were prepared as described elsewhere [30] . Equal amounts (50 mg) of protein were loaded in each lane, were subjected to 10% sodium dodecyl sulfate polyacrylamide gel electrophoresis, and were subsequently transferred to a nitrocellulose membrane. The membrane was blocked overnight with 3% bovine serum albumin in Tris-saline buffer (pH, 7.5), and immunoblotting was performed to detect iNOS2 and phosphorylated or dephosphorylated forms of p38MAPK and ERK1/2, as described elsewhere [31] .
Measurement of reactive oxygen species. To monitor the level of reactive oxygen species, the cell permeant probe H 2 DCFDA (Sigma) was used as described elsewhere [32] . Macrophages from different treatment sets were incubated with H 2 DCFDA (2 mg/mL) at room temperature for 20 min in the dark. Relative fluorescence was measured in a Perkin-Elmer LS50B Spectrofluorometer at an excitation wavelength of 510 nm and an emission wavelength of 525 nm. Fluorometric measurements were expressed in mean fluorescence intensity units.
Nitrite generation assay. Nitrite accumulation in culture was measured colorimetrically by the Griess reaction [33, 34] with use of the Nitric Oxide colorimetric Assay Kit (Boehringer Mannheim Biochemicals). Cell-free supernatants were collected from different experimental sets at different time points of infection, and nitrite levels were estimated according to the manufacturer's instructions. Data were expressed in mmol nitrite.
Isolation of RNA and real-time polymerase chain reaction (PCR). Total RNA was extracted from macrophages 6 3 ϫ 10 with use of TRI Reagent (Sigma), according to the manufacturer's protocol. Isolated RNA (1 mg) was then reverse transcribed using Revert Aid M-MuLV Reverse Transcriptase (Fermentas). The resulting complementary DNA was used for real-time PCR to detect CXCR3, iNOS, and cytokines with use of the ABI 7500 Real-time PCR system with the DNA-binding SYBR green dye (Applied Biosystems). Glyceraldehyde-3 Phosphate Dehydrogenase (GAPDH) was used as a reference. The forward and reverse specific primer sequences used were as follows: CXCR3 Forward, 5 -GCCTTCCTGCTGGCTTGTAT-3 ; CXCR3 Reverse The reaction conditions involved an initial activation step (5 min at 95ЊC) and a cycling step (denaturation for 30 s at 94ЊC, annealing for 30 s at 58ЊC, and extension for 1 min at 72ЊC for 40 cycles), followed by melting curve analysis. Detection of dequenched probe, calculation of threshold cycles, and further analysis of these data were performed using the Sequence Detector software (Applied Biosystems). Relative changes in CXCR3, iNOS2, and cytokine messenger RNA (mRNA) expression were compared with unstimulated control, were normalized to GAPDH, and were quantified by the 2
ϪddCt method.
Determination of anti-leishmanial activity of CXC chemokine in vivo. BALB/c mice (age, 8 weeks) were injected in vivo with
L. donovani amastigotes obtained from in- 7 1 ϫ 10 fected hamster spleen homogenates [35] . These groups of infected mice ( ) were treated intravenously via the tail-vein n p 5 with either phosphate-buffered saline (control mice) or IP-10 (5 mg/kg of body weight) [17] on 1, 3, and 7 days after infection. Mice were sacrificed on days 1, 7, 14, 28, and 56 after treatment. The course of visceral infection was determined microscopically using stained liver and spleen tissue imprints after Giemsa staining. Results were expressed as Leishman Donovan units [35] . After 28 days of chemokine treatment, spleens from infected BALB/c mice were removed aseptically, and a single-cell suspension was prepared as described elsewhere [17] .
T cell proliferation assay. The T cell proliferation assay was performed as described elsewhere [36] . Single cell suspensions of splenocytes from different experimental groups of infected BALB/c mice 30 days after treatment with CXC chemokine were plated in complete RPMI 1640 medium in triplicate at a concentration of cells/well in 96-well 5 1 ϫ 10 plates and were allowed to proliferate for 3 days at 37ЊC in a 5% CO 2 incubator in the presence or absence of soluble leishmanial antigen (5 mg/mL). At 18 h before they were harvested, cells were pulsed with 1 mCi (6.7 Ci/mmol) [ Densitometry analysis. Immunoblots were analyzed using a model GS-700 Imaging Densitometer and Molecular Analyst (version 1.5; Bio-Rad Laboratories).
Statistical analysis. The in vitro cultures were performed in triplicate, and a minimum of 4 mice was used per group for in vivo experiments. The data, represented as mean values ‫ע‬ standard deviations, are from 1 experiment that was performed at least 3 times. Student's t test was employed to assess the significance of the differences between the mean values of control and experimental groups. A P value of .05 was considered to be significant, and a P value !.001 was considered to be highly significant.
RESULTS

CXC chemokine, IP-10 but not IL-8, confers protection against in vitro L. donovani infection.
To determine the anti-leishmanial dose of CXC chemokines, macrophages were pretreated with 10, 25, 50, and 100 ng/mL concentrations of IP-10 or IL-8, followed by Leishmania infection. Our observation suggested that IP-10 or IL-8 pretreatment of parasitized macrophages resulted in decrease of parasitic load in a dose dependent manner up to a 50 ng/mL concentration ( Figure 1A and 1B). At 24 h after infection, IP-10-and IL-8-pretreated macrophages (50 ng/mL) showed 80% and 35% reductions, respectively, in intracellular parasitic load ( Figure 1A) . Whereas, at 48 h after infection, IP-10 and IL-8 (50 ng/mL) were able to reduce the parasitic load by 87% and 30%, respectively ( Figure 1B) . On the basis of these results, the 50 ng/mL concentration was used as the standard anti-leishmanial dose for CXC chemokines in further studies. CXCR3, the receptor for IP-10, did not show any variation between control and infected macrophages (Figure 1C) .
In vitro modulation of pro-and anti-inflammatory cytokine response by CXC chemokine during Leishmania infection. The protective immune response during leishmanial infection is intricately associated with a strong proinflammatory cytokine and chemokines response, along with the abrogation of antiinflammatory cytokines [37] . We evaluated the cytokine response in infected macrophages pretreated with either IL-8 or IP-10. Interestingly, IP-10 pretreatment was able to induce the release of proinflammatory cytokines and 6-and 3-fold increases in the level of IL-12p70 and TNF-a, respectively, compared with infected macrophages (Figure 2A and 2B ). In contrast, the release of anti-inflammatory cytokines was downregulated in IP-10-pretreated parasitized macrophages, corresponding to nearly 3-and 2-fold decreases in the level of IL-10 and TGF-b, respectively, compared with infected macrophages ( Figure 2E and 2F) . IL-8-pretreated parasitized macrophages did not show any appreciable change in cytokine release, com- Macrophages were cultured in cover glasses with complete RPMI 1640 media pretreated with 10, 25, 50, and 100 ng/mL concentrations of either IP-10 or IL-8, followed by infection with L. donovani promastigotes (macrophage:parasitic ratio of 1:10) for 4 h. Noningested promastigotes were then washed and incubated for another 20 h (A) and 44 h (B), were stained with Giemsa, and the numbers of intracellular amastigotes per 100 macrophages were counted. The bar diagrams show the number of parasites per 100 peritoneal macrophages. Changes in CXCR3 messenger RNA (mRNA) were determined by quantitative real-time polymerase chain reaction in macrophages infected with L. donovani for 4 h. The experiment was repeated 3 times, yielding similar results, and data were expressed as mean values ‫ע‬ standard deviation. Asterisks indicate statistically significant reductions in parasitic load, compared with infected macrophages. * ; ** . P ! .001 P ! .005 pared with infected macrophages. Further confirmation of the expression of the above cytokines was obtained at the mRNA level. In IP-10-pretreated parasitized macrophages, there were 6-and 8-fold inductions of TNF-a and IL-12p40 mRNA, respectively, compared with infected macrophages (Figure 2G and 2H). Both IL-10 and TGF-b showed 3-fold reductions in mRNA expression in IP-10-pretreated parasitized macrophages, compared with infected macrophages (Figure 2K and 2L). IL-8 treatment did not cause any appreciable change at the mRNA level, compared with infected macrophages. In addition to the cytokines, we also studied the release and mRNA expression of the CC chemokines, MCP-1 and MIP-1a. IP-10-but not IL-8-pretreated parasitized macrophages were able to significantly up-regulate expression of MCP-1 and MIP-1a mRNA, compared with infected macrophages ( Figure 2C, 2D , 2I, and 2J). These results were clearly indicative of the differing potentials of IP-10 and IL-8 in setting up a local milieu of proinflammatory cytokines and CC chemokines in Leishmaniainfected macrophages.
Involvement of free radicals in CXC chemokine-mediated intracellular parasite clearance. The well documented roles of reactive oxygen species and NO as major microbicidal molecules [4, 38] prompted us to perform a comparative study between IP-10 and IL-8, to understand their individual abilities in inducing the generation of these 2 free radicals during Leishmania infection, because the CXC chemokines demonstrated variable abilities in restricting intracellular parasitic load. We found that macrophages pretreated with either IP-10 or IL-8 could not significantly induce the generation of reactive oxygen species at early time points of infection ( Figure 3A) . Next, we focused our study on the release of NO at the early and late time points of Leishmania infection. There was no significant generation of NO at early time points, but interestingly, after 24 and 48 h of infection, only IP-10-pretreated parasitized macrophages could significantly ( ) induce the genera-P ! .001 tion of NO, compared with infected macrophages ( Figure 3B ). Because this generation of NO is dependent on the activation of iNOS2, we studied its expression on the protein and mRNA levels, which both demonstrated significant increases in L. donovani-infected macrophages pretreated with IP-10, compared with infected macrophages (Figure 3C and 3D) . To confirm these data, an intracellular amastigote count was performed in presence or absence of L-NMMA at 24 h and 48 h after infection. It was observed that, unlike with IL-8, IP-10-treated macrophages showed significant reductions in the parasitic load, whereas pretreatment with L-NMMA under similar experimental conditions led to a nearly 50% decrease in IP-10-mediated protection ( Figure 3E) .
MAPK family regulates the generation of host protective NO in IP-10-treated parasitized macrophages. Other reports suggesting that modulation of p38 MAPK and ERK by leish- manial parasites leads to an impaired effector response in the form of NO [10] provided us with an impetus to understand the possible regulation of NO by these MAPK-signaling molecules in IP-10-treated macrophages. We found that at an early time point, p38MAPK phosphorylation was much higher in IP-10-treated, uninfected macrophages, similar to that observed in IP-10-treated parasitized macrophages, compared with infected macrophages; in contrast, ERK1/2 phosphorylation in IP-10-treated uninfected or parasitized macrophages was much lower than that in infected macrophages ( Figure 4A ). We further probed for possible modulation of IP-10-induced leishmanicidal activity in the presence of p38MAPK and ERK inhibitors. Interestingly, there was a drastic increase in intracellular parasitic load ( Figure 4B ) along with a decrease in NO generation and iNOS2 mRNA expression ( Figure 4C and 4D) in macrophages treated with both SB203580 and IP-10, compared with IP-10-treated parasitized macrophages. Treatment with PD098059 in the presence of IP-10 caused a slight reduction in intracellular parasitic load ( Figure 4B ) along with a slight increase in NO generation and iNOS2 mRNA expression, compared with IP-10-treated macrophages ( Figure 4C and 4D) .
IP-10 treatment causes almost complete cure of L. donovani-infected BALB/c mice. Because treatment with IP-10 demonstrated a far greater potential than IL-8 in restricting in vitro Leishmania infection, we studied the therapeutic properties of IP-10 in a murine model of visceral leishmaniasis. Two groups of L. donovani-infected BALB/c mice were either left untreated or were treated with IP-10 (5 mg/kg of body weight) on day 1, 3, and 7 after infection. After 14 days of infection, treatment with IP-10 led to 75% suppression of infection in the liver and 70% suppression of infection in the spleen ( Figure  5A and 5B). Interestingly, on day 28 of infection, treatment Macrophages were pretreated and infected as described in 6 1 ϫ 10 the figure 2 legend. These cells were incubated for 6 h, 12 h, 24 h, and 48 h for maximum nitrite generation, and cell-free supernatants obtained were subjected to Greiss method assay as described in Materials and Methods. Asterisks indicate statistically significant induction of nitrite generation, compared with infected macrophages. ** . C, The nature of inducible nitric oxide synthase (iNOS) expression was determined by Western blot P ! .005 analysis in macrophages pretreated with IP-10 or IL-8 for 4 h (50 ng/mL), followed by L. donovani infection as described in the figure 2 legend. The blot shown is a representative of experiments performed in triplicate. Band intensities were analyzed by densitometry. D, The effect of CXC chemokine pretreatment on the expression levels of iNOS2 messenger RNA (mRNA) transcripts in macrophages infected with L. donovani for 4 h was measured by quantitative real-time polymerase chain reaction. Data are presented as fold change, compared with uninfected, untreated control macrophages. * , compared with infected macrophages. E, Macrophages (as described in the figure 1 legend) cultured on cover glasses were either kept P ! .001 untreated or treated with L-N-monomethyl arginine (L-NMMA) (0.4 mmol/L) for 1 h prior to chemokine treatment, followed by L. donovani infection, and were kept for another 24 h or 48 h. After that, cover glasses were stained with Giemsa and assessed for intracellular parasite number. Pretreatment with L-NMMA significantly inhibited IP-10-mediated parasite killing, compared with levels in corresponding IP-10-pretreated infected controls. *P ! , for L-NMMA. Results are presented as mean values ‫ע‬ standard deviation of results from 3 independent experiments. .001 with IP-10 had resulted in a marked decrease in parasitic burden in liver (∼94%;
) and spleen (91%; ) (Figure P ! .001 P ! .001 5A and 5B).
IP-10 treatment of Leishmania-infected mice recovers the impairment in lymphoproliferation of splenocytes. Because impairment of cell-mediated immune response in active visceral leishmaniasis patients is reflected by marked T cell anergy specific to Leishmania antigens [39, 40] , we performed a T cell proliferation assay where splenocytes from differently treated mice were stimulated with soluble leishmanial antigen. Splenocytes from control and infected mice showed low T cell proliferation, but IP-10-treated infected mice showed a nearly 15-fold increase in lymphoproliferative response, compared with splenocytes from infected mice (Figure 6 ).
IP-10 confers protection through NO and Th1 cytokines in
Leishmania-infected mice. Effective clearance of Leishmania parasites requires Th1 cells to secrete a substantial amount of IFN-g [41] , whereas susceptibility to Leishmania parasites is mainly mediated by Th2 cytokines, such as IL-10. To determine the type of immune response induced by IP-10 treatment in experimental visceral leishmaniasis, analysis of cytokine production was performed in spleen cells of differently treated control or infected animals. Comparative cytokine profiles (Figure 7A-7J ) demonstrated high levels of IL-10 and IL-4 in infected mice and low levels of TNF-a, IFN-g, and IL-12 mRNA and protein in infected and untreated mice. In contrast, IP-10-treated infected mice showed nearly 3-and 4-fold decreases in both IL-4 and IL-10 mRNA and protein, respectively, com- , and 120 min, and in some sets, they were treated with IP-10 for 4 h followed by Leishmania infection for 30, 60, and 120 min. The cells were lysed and subjected to Western blot with anti-pERK1/2, pp38MAPK, p38MAPK, and ERK1/2 as described in Materials and Methods. B, In a separate experiment, the macrophages were treated with SB203580 (SB; 10 mg/mL) or PD098059 (PD; 100 mmol/L) for 2 h, followed by IP-10 treatment and Leishmania infection for 24 h or 48 h. After that, cover glasses were stained with Giemsa stain and assessed for intracellular parasite number. Pretreatment with SB203580 significantly inhibited IP-10-mediated parasite killing, compared with levels in corresponding IP-10-pretreated infected controls. * for SB203580. P ! .001 C, Macrophages cultured in a 24-well plate ( cells/mL) were pretreated and infected as described for figure 3B. For maximum nitrite generation, 6 1 ϫ 10 cell-free supernatants were collected after 48 h of infection and were subjected to the Greiss method assay as described in the Materials and Methods. Asterisks indicate statistically significant induction of nitrite generation, compared with IP-10-pretreated infected macrophages. * . P ! .001 D, Expression levels of inducible nitric oxide synthase 2 (iNOS2) messenger RNA (mRNA) transcripts in macrophages infected with L. donovani for 4 h, which were pretreated and infected as in figure 3B , were measured by quantitative real-time polymerase chain reaction. Data are presented as fold change, compared with uninfected, untreated control macrophages. * , compared with IP-10-pretreated infected macrophages. The data P ! .001 represent the mean values ‫ע‬ standard deviation of results from 3 independent experiments that all yielded similar results.
pared with infected mice. On the other hand, IFN-g, TNF-a, and IL-12 showed nearly 5-, 4-, and 3-fold increases at the protein level, respectively, and 16-, 9-, and 13-fold increases at the mRNA level, respectively, compared with infected mice. In IP-10-treated control mice, a slight increase in the expression of TNF-a, IFN-g, and IL-12 protein and mRNA was observed, compared with untreated mice. Further, we determined that splenocytes from IP-10-treated infected mice produced 15-fold more NO, compared with splenocytes from infected mice, accompanied with a strong induction of iNOS2 mRNA ( Figure  7K and 7L).
DISCUSSION
Visceral leishmaniasis, associated with impairment in both proinflammatory cytokine response and generation of free radicals, helps the parasite to establish itself within the hostile environment of the host macrophage [42] . Other studies with CC chemokines from our laboratory have demonstrated restoration of the impaired effector response, thereby rendering protection against Leishmania infection [17, 43] . There is no clear understanding about the immunoprotective role of CXC chemokines in visceral leishmaniasis, although IP-10 satisfactorily restricts the early onset of Leishmania amazonensis infection [44] .
Here we have evaluated the immunoprotective property of IP-10 in both in vitro and in vivo models of visceral leishmaniasis. Leishmania promastigotes inhibited IP-10 but induced IL-8 production [45] . Thus, in the in vitro studies, we tested the immunoprotective properties of IP-10 and IL-8 in restricting Leishmania-induced pathogenesis. At a 50 ng/mL concentration, IP-10 was able to restrict intracellular parasite survival more significantly than IL-8 ( Figure 1) . In probing the probable effector mechanism, we observed a strong proinflammatory cytokine and chemokine response in IP-10-pretreated parasitized macrophages. IL-8-pretreated parasitized macrophages had low levels of chemokines and proinflammatory cytokines, similar to that observed in infected macrophages (Figure 3A-3D and 3G-3J ). In contrast, IP-10 was able to suitably down-regulate the disease-promoting anti-inflammatory cytokines, such as IL-10 and TGF-b, a down-regulation that was not observed in IL-8-pretreated parasitized macrophages (Figure 3E, 3F, 3K, and 3L) . Thus, this efficient regulation of proand anti-inflammatory cytokines by IP-10 might regulate the generation of NO. Proinflammatory cytokines play a critical role in the induction of NO via iNOS2 during visceral leishmaniasis [46] , whereas IL-10 inhibits NO [47] . NO generation, along with iNOS2 expression, was significantly elevated in IP-10-pretreated, but not in IL-8-pretreated parasitized macrophages ( Figure 3C and 3D) . This iNOS2-mediated parasite killing by IP-10 was found to be severely abrogated when L-NMMA was applied (Figure 3E ), confirming the involvement of NO in IP-10-mediated intracellular parasite clearance. This was similar to the TNF-a-mediated induction of NO in MIP1a-or MCP-1-pretreated parasitized macrophages [16] ; however, the strong generation of reactive oxygen species by CC chemokines did not correlate with that of IP-10 [43] .
Reports have implicated the regulation of NO via iNOS2 through the antagonistic regulation of p38MAPK and ERK signaling pathways during Leishmania infection. CD40, a key signaling molecule, up-regulates IL-10 through ERK1/2, which in turn inhibits activation of p38MAPK, thereby down-regulating IL-12 and iNOS [10, 48, 49] . IP-10 pretreatment restored the impaired p38MAPK phosphorylation in parasitized macrophages and abrogated the ERK1/2 phosphorylation ( Figure 4A ). Inhibition of p38MAPK in the presence of IP-10 resulted in an increase in parasitic burden with impaired NO production. ERK1/2 inhibition in the presence of IP-10 caused a significant reduction in intracellular parasitic load and with enhanced NO production ( Figure 4B-4D) .
The in vivo studies were focused on IP-10, and its immunotherapeutic property of controlling disease progression was studied. In vivo experiments demonstrated that IP-10 treat- ment could significantly restrict parasite growth in spleen and liver after 28 days of infection, and this protection was observed to persist for 56 days of infection ( Figure 5 ). The T cell impairment associated with visceral leishmaniasis [39, 40] was found to be rescued by IP-10; splenocytes isolated at 28 days of infection from mice treated with IP-10 showed a strong lymphoproliferative response ( Figure 6 ). The cytokine profile suggests that IP-10 could generate a strong Th1 response in IP-10-treated infected mice ( Figure 7A-7C and 7F-7H ). Production of IL-10, an immunosuppressive cytokine, and IL-4 was found to be abrogated in IP-10-treated mice ( Figure 7D , 7E, 7I, and 7J), thereby suggesting a protective role of IP-10 in mediating the shift from Th2 to Th1 response in L. donovaniinfected mice, along with possible activation of IFN-g-producing cells [50] . Similar to CXC chemokines, CC chemokines have been shown to confer long-term protection against experimental visceral leishmaniasis through the induction of IL-12, IFN-g, and TNF-a [17] . This protective response of IP-10 was found to be further mediated by the induction of iNOS2 and production of NO ( Figure 7K and 7L). Collectively, these findings provide mechanistic insights into the immunoprotective role of IP-10 in both in vitro and in vivo models of visceral leishmaniasis. IP-10 treatment rescued the impaired immune response associated with experimental visceral leishmaniasis, leading to a critical skewing toward a proinflammatory effector response. Thus, IP-10 can be used as a novel therapeutic tool to overcome Leishmania-induced pathogenesis.
